Barclays raised the firm’s price target on DexCom (DXCM) to $93 from $90 and keeps an Equal Weight rating on the shares. The firm made “elatively minor changes” to its model to reflect the company’s Q1 results and revised 2025 guidance.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DXCM:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue